Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.59 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13654202 | 0.90 | TAS1R3 (0.48) | TAS1R3TAS1R1NPSR1PPARGPPARA | |
| SCHEMBL1105516 | 0.90 | TAS1R3 (0.48) | TAS1R3TAS1R1NPSR1PPARGPPARA | |
| SCHEMBL12379286 | 0.90 | TAS1R3 (0.48) | TAS1R3TAS1R1NPSR1PPARGPPARA | |
| SCHEMBL20299918 | 0.90 | TAS1R3 (0.48) | TAS1R3TAS1R1NPSR1PPARGPPARA | |
| SCHEMBL20299850 | 0.87 | NPSR1 (0.54) | TAS1R3TAS1R1NPSR1MEN1KMT2A | |
| SCHEMBL20299847 | 0.87 | NPSR1 (0.54) | TAS1R3TAS1R1NPSR1MEN1KMT2A | |
| SCHEMBL28568590 | 0.86 | P2RY6 (0.44) | TAS1R3TAS1R1MEN1CYP2C9KMT2A | |
| SCHEMBL15128048 | 0.82 | MLYCD (0.54) | MEN1CYP2C19KMT2AALDH1A1 | |
| SCHEMBL26820886 | 0.81 | TAS1R3 (0.70) | TAS1R3TAS1R1NPSR1MEN1CYP2C9 | |
| SCHEMBL13382238 | 0.81 | PPARG (0.61) | TAS1R3TAS1R1NPSR1PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200085779-A1 | Compounds for the Treatment of Bovine or Swine Respiratory Disease | INTERVET INC. (US) | 2020-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200085779-A1 | Compounds for the Treatment of Bovine or Swine Respiratory Disease | PIGS, BTD, PPARD | TAS1R3 1569/4885TAS1R1 1537/4885NPSR1 2251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.